ArticleImmunometabolism (Cobham, Surrey)2025
Metabolic deficits and immune dysfunction in aging people living with HIV.
Article in Immunometabolism (Cobham, Surrey), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Immunometabolism drives metabolic and infectious disease progression through bidirectional metabolic reprogramming and epigenetic remodeling.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Cellular metabolism is crucial for energy production, which regulates cell function and survival. In recent years, the importance of metabolism in modulating immune cell proliferation, differentiation, and function has become a prominent area of research. However, little is still known about the metabolic regulation of B cell function and humoral immunity, both in healthy individuals as well as in those with various conditions and diseases. In this viewpoint, we will discuss the current understanding of immunometabolic regulation of humoral responses in aging people living with HIV, and in people without HIV. We propose the possibility to target metabolic molecules and pathways to prevent the negative effects of aging and HIV and progress towards an overall better immune system, not only in individuals with HIV but also in those living with other inflammatory conditions and diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.